Abstract
In this paper we describe test methods useful to evaluate the performance of Ge/ Ga generators and to assess radionuclidic purity of the eluates. In our tests on the elution profile of the generator, we found that less than 8.0 ml are sufficient to recover > 98 % of the activity. Elution yield was conforming the manufacturer specifications, being initially > 85 % and still > 64 % after 7 months of use. 68Ge breakthrough in the eluates was limited; even if radionuclidic purity was > 99.99 % , further analyses, in addition to physical tests, is recommended in order to assess chemical impurities that could determine interferences in labelling procedures.
Keywords: Ga/, Ge generator, radionuclidic purity, quality assurance
Current Radiopharmaceuticals
Title: Acceptance Tests and Quality Control of Ge/ Ga Generators
Volume: 2 Issue: 3
Author(s): Gianfranco Cicoria, Mario Marengo, Davide Pancaldi, Donato Di Pierro, Anna Rizzello, Filippo Lodi, Stefano Fanti and Stefano Boschi
Affiliation:
Keywords: Ga/, Ge generator, radionuclidic purity, quality assurance
Abstract: In this paper we describe test methods useful to evaluate the performance of Ge/ Ga generators and to assess radionuclidic purity of the eluates. In our tests on the elution profile of the generator, we found that less than 8.0 ml are sufficient to recover > 98 % of the activity. Elution yield was conforming the manufacturer specifications, being initially > 85 % and still > 64 % after 7 months of use. 68Ge breakthrough in the eluates was limited; even if radionuclidic purity was > 99.99 % , further analyses, in addition to physical tests, is recommended in order to assess chemical impurities that could determine interferences in labelling procedures.
Export Options
About this article
Cite this article as:
Cicoria Gianfranco, Marengo Mario, Pancaldi Davide, Di Pierro Donato, Rizzello Anna, Lodi Filippo, Fanti Stefano and Boschi Stefano, Acceptance Tests and Quality Control of Ge/ Ga Generators, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030165
DOI https://dx.doi.org/10.2174/1874471010902030165 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry Can Anthropometric and Body Composition Measurements During Pregnancy be Used to Predict Preeclampsia Risk?
Current Women`s Health Reviews Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans
Current Drug Metabolism Treatment and Response to Statins: Gender-related Differences
Current Medicinal Chemistry Functional Characterization of Chitin and Chitosan
Current Chemical Biology Comparative Bioavailability of Two Oral Formulations of Clozapine in Steady State Administered in Schizophrenic Volunteers Under Individualized Dose Regime
Current Clinical Pharmacology The Psychoactive Effects of Aromatic Amino Acids
Current Nutrition & Food Science In-vitro Antioxidant activity of ‘Aswathy Chooranam’- a Siddha Drug
Current Traditional Medicine Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases
Current Vascular Pharmacology Editorial [Hot Topic: Sepsis (Guest Editor: David E. Joyce)]
Current Drug Targets Buxus sempervirens L. Improves Lipid Profile in Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets Exercise and Cognitive-Behavioural Treatment in Fibromyalgia Syndrome
Current Pharmaceutical Design Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy
Current Pharmaceutical Design Biological Basis of Ageing, Age-related Diseases and Interventions
Current Pharmacogenomics and Personalized Medicine Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids
Current Neuropharmacology Editorial [Hot topic:Expression and Refolding Technologies for Production of Recombinant Proteins (Guest Editors: Tsutomu Arakawa and Kouhei Tsumoto)]
Current Pharmaceutical Biotechnology Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention (Discontinued) Mitophagy in Neurodegeneration: An Opportunity for Therapy?
Current Drug Targets Genitourinary Complications of Diabetes Mellitus: An Overview of Pathogenesis, Evaluation, and Management
Current Diabetes Reviews Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease
Current Alzheimer Research